Final answer:
Immediate duplicate sequences in Ebola virus samples are performed as experimental controls to verify the accuracy of the sequencing procedure and guarantee data reliability. This helps in accurately identifying the virus's genetic material, which is crucial for developing effective treatments and containment strategies. Reproducibility and technical accuracy in sequencing are vital in the study of infectious diseases.
Step-by-step explanation:
The goal behind sequencing 99 Ebola virus samples from 78 confirmed patients was multifaceted. Immediate duplicate sequences on some patients are experimental controls, often known as technical replicates, designed to verify the accuracy of the sequencing procedure. Performing immediate duplicate sequences helps ensure that the data obtained is accurate and reliable, as even subtle technical errors in sequencing can lead to significant misinterpretations of how a virus is changing over time or between different patients.
These repeat sequences are paramount because of the high stakes involved in understanding and treating infectious diseases like Ebola. An accurate genetic sequence of a virus is critical for developing effective treatments, vaccines, and diagnostic methods. This is especially important in a virus like Ebola because of the potential for rapid spread and the high mortality rate associated with it. In the context of a high mutation rate pathogen such as Ebola, immediate duplicate sequences serve an additional purpose beyond mere verification; they can potentially catch early mutations within a patient’s virus population if sequencing is done at distinct time points.
The practice of duplicating sequences cannot be understated as it ties directly to ensuring reproducibility in scientific research, which is fundamental to the credibility of any study's findings, especially in the field of viral genetics and epidemiology.